1. Home
  2. FDUS vs ABCL Comparison

FDUS vs ABCL Comparison

Compare FDUS & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FDUS
  • ABCL
  • Stock Information
  • Founded
  • FDUS 2011
  • ABCL 2012
  • Country
  • FDUS United States
  • ABCL Canada
  • Employees
  • FDUS N/A
  • ABCL N/A
  • Industry
  • FDUS Finance/Investors Services
  • ABCL Biotechnology: Pharmaceutical Preparations
  • Sector
  • FDUS Finance
  • ABCL Health Care
  • Exchange
  • FDUS Nasdaq
  • ABCL Nasdaq
  • Market Cap
  • FDUS 693.6M
  • ABCL 719.0M
  • IPO Year
  • FDUS 2011
  • ABCL 2020
  • Fundamental
  • Price
  • FDUS $20.97
  • ABCL $2.76
  • Analyst Decision
  • FDUS Hold
  • ABCL Buy
  • Analyst Count
  • FDUS 1
  • ABCL 3
  • Target Price
  • FDUS $22.00
  • ABCL $8.50
  • AVG Volume (30 Days)
  • FDUS 235.4K
  • ABCL 2.5M
  • Earning Date
  • FDUS 10-31-2024
  • ABCL 11-04-2024
  • Dividend Yield
  • FDUS 10.01%
  • ABCL N/A
  • EPS Growth
  • FDUS 26.64
  • ABCL N/A
  • EPS
  • FDUS 2.78
  • ABCL N/A
  • Revenue
  • FDUS $145,008,000.00
  • ABCL $32,962,000.00
  • Revenue This Year
  • FDUS $12.92
  • ABCL N/A
  • Revenue Next Year
  • FDUS $1.80
  • ABCL $38.78
  • P/E Ratio
  • FDUS $7.55
  • ABCL N/A
  • Revenue Growth
  • FDUS 19.57
  • ABCL N/A
  • 52 Week Low
  • FDUS $18.41
  • ABCL $2.34
  • 52 Week High
  • FDUS $21.00
  • ABCL $6.06
  • Technical
  • Relative Strength Index (RSI)
  • FDUS 74.60
  • ABCL 50.74
  • Support Level
  • FDUS $19.02
  • ABCL $2.61
  • Resistance Level
  • FDUS $20.84
  • ABCL $3.18
  • Average True Range (ATR)
  • FDUS 0.24
  • ABCL 0.19
  • MACD
  • FDUS 0.10
  • ABCL -0.02
  • Stochastic Oscillator
  • FDUS 98.49
  • ABCL 38.24

About FDUS Fidus Investment Corporation

Fidus Investment Corp is an externally managed, closed-end, non-diversified management investment company that has elected to be treated as a business development company. The company provides customized debt and equity financing solutions to lower middle-market companies. Its investment objective is to provide attractive risk-adjusted returns by generating both current income from debt investments and capital appreciation from equity related investments. The company's portfolio of investments is comprised of securities of companies from different industries such as, Information Technology Services, Business Services, Healthcare Products among others.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: